[Form 4] Addus HomeCare Corp. Insider Trading Activity

Rhea-AI Filing Summary

Allison R. Dirk, Chairman and CEO of Addus HomeCare Corp. (ADUS), reported option exercise and stock sales on 08/20/2025. She exercised 25,000 employee stock options with a $19.71 exercise price, resulting in ownership of 25,000 shares from that exercise. On the same date she sold a total of 25,000 common shares in two blocks: 17,560 shares at a weighted average price of $114.71 and 7,440 shares at a weighted average price of $115.53. After these transactions her beneficial ownership is reported as 166,461 shares. The filing notes all options were fully vested and sale price ranges are provided in footnotes.

Positive

• Options were fully vested, enabling lawful exercise of 25,000 shares
• Sales disclosed with weighted-average prices and price ranges, providing transparency

Negative

• CEO reduced direct holdings from 191,461 to 166,461 shares through sales
• Significant insider sell volume (25,000 shares) could be viewed negatively by some investors

Insights

Corporate Governance Expert

TL;DR: CEO exercised vested options and sold an equal number of shares, a routine liquidity event that does not by itself change control.

The filing documents a common executive liquidity transaction: exercise of fully vested options at a $19.71 strike followed by sales at roughly $114.7–$115.5 per share. This realized substantial economic gain given the spread between exercise price and sale price. The transactions were executed on the same date and reduce the reporting person’s direct holdings from 191,461 to 166,461 shares. No hedging, loans, or derivative disposal beyond the exercise are disclosed. From a governance perspective, this appears routine and consistent with option exercise for cashing out gains rather than signaling a corporate event.

Securities Analyst

TL;DR: Material only as an insider liquidity event; impact on market or control is likely limited.

The exercise of 25,000 options at $19.71 and immediate sale of 25,000 shares at ~ $115 implies a material realized gain per share but represents a small fraction of outstanding float for most mid-cap issuers. The filing discloses weighted-average sale prices and offers to provide per-trade details, which supports transparency. There is no indication of changes to compensation structure, grants, or additional derivative activity. Investors should view this as a personal liquidity action by the CEO rather than new corporate guidance or governance change.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALLISON R DIRK

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		M		25,000	A	$19.71	191,461	D
Common Stock	08/20/2025		S		17,560	D	$114.71(1)	173,901	D
Common Stock	08/20/2025		S		7,440	D	$115.53(2)	166,461	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$19.71	08/20/2025		M			25,000	(3)	01/21/2026	Common Stock	25,000	$0	25,000	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.10 to $115.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.10 to $115.89, inclusive.

3. All options are fully vested.

	/s/ Brian Poff, Attorney-in-Fact for R. Dirk Allison	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did ADUS insider Allison R. Dirk report on Form 4?

The filing reports the exercise of 25,000 employee stock options at a $19.71 strike and the sale of 17,560 shares at a weighted average of $114.71 and 7,440 shares at a weighted average of $115.53 on 08/20/2025.

How many ADUS shares does Allison R. Dirk own after these transactions?

The reporting person beneficially owned 166,461 shares following the reported transactions.

Were the exercised options vested for the ADUS CEO?

Yes. The Form 4 states that all options are fully vested.

What were the exercise and sale prices reported?

The exercised option strike price was $19.71. Sales were at weighted averages of $114.71 and $115.53, with trade ranges disclosed in footnotes.

Does the Form 4 indicate these trades were part of a 10b5-1 plan?

The form includes the checkbox language for Rule 10b5-1 but does not explicitly mark that the transactions were made pursuant to a 10b5-1 plan in the provided content.